Breaking down GLP-1 patient engagement strategies, challenges

As many patients decide whether to take glucagon-like peptide 1 agonists (or GLP-1s), providers face various new patient engagement challenges. What patient engagement strategies can providers pursue to achieve shared decision-making, even when their patients decide to take GLP-1 compounds? In this episode, we hear one local dietitian share her experience guiding patients through the decision to take GLP-1s and we'll also touch base with one of our senior staff members to get a more comprehensive perspective on patient engagement trends in this area.

Featuring: Kate, a local dietitian in the Boston area

Sara Heath, executive editor at Xtelligent Healthcare

In this episode, we'll cover

• One dietitian’s experience with patient engagement on the topic of GLP-1s and weight loss
• The need for robust care management in GLP-1 usage
• How to respond when patients want to take/are taking a GLP-1 compound

and more!

References

Patient education tips for GLP-1, weight loss drug treatment (https://techtarget.com/patientengagement/feature/Patient-education-tips-for-GLP-1-weight-loss-drug-treatment)

Is care management missing from the GLP-1 drug discourse? (https://www.techtarget.com/patientengagement/feature/Is-care-management-missing-from-the-GLP-1-drug-discourse)

To learn more about patient engagement, check out our Patient Engagement site.

To learn more about GLP-1s, visit our Pharma Life Sciences site.

And to watch video clips from the conversation, subscribe to our YouTube channel, @HealthcareStrategies.